USPTO serial 76581120
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 9, 2005 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Jul 20, 2005 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 16, 2005 | LOAP | LETTER OF ABANDONMENT PROCESSED | — |
| Jun 16, 2005 | PAPER RECEIVED | — | |
| Feb 2, 2005 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 21, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 1, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 12, 2004 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 4, 2004 | ALIE | ASSIGNED TO LIE | — |
| Sep 27, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2004 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Sep 26, 2004 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 24, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 30, 2004 | NWAP | NEW APPLICATION ENTERED | — |